A comprehensive analysis of 30 Biomarkers and their association with cardiovascular outcomes and mortality in the UK Biobank

Back

ESC Professional Premium Access

A comprehensive analysis of 30 Biomarkers and their association with cardiovascular outcomes and mortality in the UK Biobank

Session: Defining prevention strategies

Topic: Biomarkers

Speaker: Doctor S. Kany (Hamburg, DE)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Shinwan Kany

The University Medical Center Hamburg-Eppendorf, Hamburg (Germany)

1 presentation

0 follower

6 more presentations in this session

Potential lifetime benefit of applying two-step ESC prevention strategy

Speaker: Ms T. Van Trier (Amsterdam, NL)

Atrial fibrillation diagnosed at different phases of myocardial infarction are all associated with excess risk

Speaker: Doctor P. Svensson (Stockholm, SE)

Effect of smoking initiation age on nicotine dependence

Speaker: Professor K. Hasegawa (Kyoto, JP)

Comparing electrophysiological biomarkers and circulating cardiac biomarkers in predicting cardiovascular mortality and all-cause mortality in the akershus sleep apnea (ASAP) epidemiological cohort

Speaker: Mr H. Nahoui (Oslo, NO)

Impact of a multimorbidity-focused national general practice chronic disease programme on cardiovascular risks factors

Speaker: Doctor O. Oreilly (IE)

Access the full session

Defining prevention strategies

Speakers: Doctor S. Kany, Ms T. Van Trier, Doctor P. Svensson, Professor K. Hasegawa, Mr H. Nahoui...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources